Ventas (VTR) Price Target Raised to $78.00 by Raymond James

Ventas (VTR) price target raised to $78.00 by Raymond James, a 5.41% increase. Analysts have a positive outlook on the healthcare real estate investment trust, with a consensus rating of "Outperform" and an average one-year price target of $77.25. The estimated GF Value for Ventas in one year is $59.16, suggesting a downside of 14.41% from the current price.

Raymond James Financial has reaffirmed its "outperform" rating for Ventas (NYSE: VTR) and raised the price target to $78.00, indicating a potential upside of 12.22% from the stock's previous close. This move comes after Ventas reported a quarterly earnings per share (EPS) of $0.87, surpassing analysts' expectations. The company has set its FY 2025 guidance at 3.410-3.46 EPS, showing strong growth prospects.

The latest earnings report highlights Ventas' robust performance, with revenue growing by 18.3% year-over-year. The company's net margin of 3.61% and return on equity of 1.75% underscore its financial health. The insider activity, with a total of 307,340 shares sold in the last 90 days, shows that insiders are not overly optimistic about the stock's future prospects.

Analysts from various firms have provided a mixed outlook on Ventas. While Raymond James, Scotiabank, and Royal Bank of Canada have raised their price targets, Wall Street Zen downgraded the stock to a "sell" rating. Overall, the consensus rating for Ventas is "Moderate Buy," with an average one-year price target of $77.25. The estimated GF Value for Ventas in one year is $59.16, suggesting a downside of 14.41% from the current price.

Ventas' recent performance and strong fundamentals have driven its stock price to new highs, but the market's reaction to its latest earnings report indicates that investors are reassessing their outlook. The company's ability to maintain its growth trajectory and navigate potential challenges will be crucial in determining its future performance.

References:
[1] https://www.marketbeat.com/instant-alerts/ventas-nysevtr-given-outperform-rating-at-raymond-james-financial-2025-08-22/
[2] https://simplywall.st/stocks/us/real-estate/nyse-vtr/ventas/news/ventas-vtr-valuation-how-does-the-recent-earnings-dip-shape